Advertisement
AJOG Home
Advanced SearchSave search
Full length article| Volume 105, ISSUE 3, P386-393, October 01, 1969

A follow-up study of patients with cervical dysplasia

  • Ralph M. Richart
    Affiliations
    Department of Pathology, College of Physicians and Surgeons, Columbia University New York, New York, USA

    Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University New York, New York, USA

    the Obstetrical and Gynecological Service (The Sloane Hospital) of the Presbyterian Hospital New York, New York, USA
    Search for articles by this author
  • Bruce A. Barron
    Affiliations
    Department of Pathology, College of Physicians and Surgeons, Columbia University New York, New York, USA

    Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University New York, New York, USA

    the Obstetrical and Gynecological Service (The Sloane Hospital) of the Presbyterian Hospital New York, New York, USA
    Search for articles by this author
DOI:https://doi.org/10.1016/0002-9378(69)90268-3
A follow-up study of patients with cervical dysplasia
Previous ArticleRecurrent carcinoma of the cervix
Next ArticleAutotransfusions of previously frozen blood in elective gynecologic surgery
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Five hundred and fifty-seven patients with cervical dysplasia detected cytologically were followed without biopsy or therapy to examine the natural history of the disease. At the end of the follow-up period transition probabilities were calculated and transit times of mild, moderate, and severe dysplasia to carcinoma in situ were computed. These transit times ranged from a median of 86 months for patients with mild dysplasia to 12 months for a patient with severe dysplasia. The median transit time to carcinoma in situ for all dysplasias was 44 months.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

      1. Barron, B. A., and Richart, R. M.: In press.

        • Dougherty C.M.
        • Torres J.
        • Cotton N.
        Proc. First International Congress of Exfoliative Cytology. 1961: 103-109
        • Dunn Jr., J.E.
        • Martin P.L.
        Cancer. 1967; 20: 1899
        • Fox C.H.
        Am. J. Obst. & Gynec. 1967; 99: 960
        • Friedell C.
        • Hertig A.T.
        • Younge P.A.
        ed. 4. Carcinoma In Situ of the Uterine Cervix. Charles C Thomas, Publisher, Springfield, Illinois1960
        • Galvin G.A.
        • Jones H.W.
        • TeLinde R.W.
        Am. J. Obst. & Gynec. 1958; 70: 808
        • Gore H.
        • Hertig A.T.
        Gray L. Dysplasia, Carcinoma In Situ and Microinvasive Carcinoma of the Cervix Uteri. Charles C Thomas, Publisher, Springfield, Illinois1964: 83-109
        • Greene R.R.
        Am. J. Obst. & Gynec. 1955; 70: 808
        • Johnson L.D.
        • Hertig A.T.
        • Hinman C.H.
        • Easterday C.L.
        Obst. & Gynec. 1960; 16: 133
        • Jordan M.J.
        • Bader G.M.
        • Day E.
        Am. J. Obst. & Gynec. 1964; 89: 160
        • Kirkland J.A.
        J. Clin. Path. 1963; 16: 150
        • Kirkland J.A.
        J. Obst. & Gynaec. Brit. Comm. 1963; 70: 232
        • Koss L.G.
        • Stewart F.W.
        • Foote P.W.
        • Jordan M.J.
        • Bader G.M.
        • Day E.
        Cancer. 1963; 16: 1160
        • Lambert B.
        • Woodruff J.D.
        Cancer. 1963; 16: 1141
        • Lerch V.
        • Okagaki T.
        • Austin J.H.
        • Kevorkian A.Y.
        • Young P.A.
        Acta cytol. 1963; 7: 183
        • McKay D.G.
        • Terjanian B.
        • Poschyachinda D.
        • Younge P.A.
        • Hertig A.T.
        Obst. & Gynec. 1959; 13: 2
        • McLaren H.C.
        • Attwood M.E.
        Proc. First International Congress of Exfoliative Cytology. 1961: 133-135
        • Nieburgs H.E.
        Cancer. 1963; 16: 141
        • Okagaki T.
        • Lerch V.
        • Younge P.A.
        • McKay D.G.
        • Kevorkian A.Y.
        Acta cytol. 1962; 6: 343
        • Park W.W.
        Lancet. 1956; 1: 701
        • Patten S.F.
        Lewis Jr., G.C. Wentz W.B. Jaffe R.M. New Concepts in Gynecological Oncology. F. A. Davis Company, Philadelphia1966: 33-44
        • Peckham B.
        • Greene R.R.
        Am. J. Obst. & Gynec. 1957; 74: 804
        • Rawson A.J.
        • Knoblich R.
        Am. J. Obst. & Gynec. 1957; 73: 120
        • Richart R.M.
        Am. J. Obst. & Gynec. 1963; 87: 474
        • Richart R.M.
        Am. J. Obst. & Gynec. 1964; 89: 723
        • Richart R.M.
        Cancer. 1966; 19: 395
        • Richart R.M.
        Cancer. 1966; 19: 1635
        • Richart R.M.
        Clin. Obst. & Gynec. 1968; 5: 748
        • Richart R.M.
        • Sciarra J.J.
        Am. J. Obst. & Gynec. 1968; 101: 200
        • Richart R.M.
        • Vaillant H.W.
        Cancer. 1966; 18: 1474
        • Scott R.B.
        • Ballard L.A.
        Ann. New York Acad. Sc. 1962; 97: 767
        • Stern E.
        • Neely P.M.
        Acta cytol. 1963; 7: 357
      33. Wied G.L. Proc. First International Congress of Exfoliative Cytology, Philadelphia J. B. Lippincott Company, 1961: 283-298

      Article Info

      Footnotes

      ☆This investigation was supported in part by United States Public Health Service Fellowship No. 5-K3-CA-13,975 and United States Public Health Service Research Grant No. CA-07060-06.

      Identification

      DOI: https://doi.org/10.1016/0002-9378(69)90268-3

      Copyright

      © 1969 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2022 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX